Other factors that affect the effectiveness of treatment include the absence of tumor expression of MHC class I molecules (20, 21), low numbers of CD4+ T cell infiltrates in tumor tissue, high numbers of myeloid-derived suppressor cells (MDSC), and low expression of PD-L1 on cancer cells. This evidence concerns the gene CD274 and neoplasm.